<

VALNEVA (EPA:VLA) Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate

Transparency directive : regulatory news

31/01/2022 22:15



Other stories

20/04/2024 09:42
20/04/2024 13:10
20/04/2024 14:36
20/04/2024 14:31
20/04/2024 10:39
20/04/2024 08:26
20/04/2024 11:20
20/04/2024 11:56
19/04/2024 22:08
20/04/2024 13:27
20/04/2024 11:25
20/04/2024 12:21
20/04/2024 13:26
20/04/2024 12:09
18/04/2024 17:06
20/04/2024 05:34
19/04/2024 01:56
20/04/2024 05:35
19/04/2024 12:17
19/04/2024 18:00
20/04/2024 10:14
20/04/2024 16:12
20/04/2024 11:01
20/04/2024 07:00
20/04/2024 10:45
20/04/2024 16:16
20/04/2024 08:21
20/04/2024 16:00
20/04/2024 14:19
20/04/2024 10:29
20/04/2024 09:37
19/04/2024 21:18
19/04/2024 14:00
19/04/2024 23:53
20/04/2024 10:53
20/04/2024 08:56
20/04/2024 10:22